Proud of our clients!
One of our esteemed clients, NeuroSense Therapeutics, has recently achieved a significant milestone in its mission to develop groundbreaking treatments for ALS.
NeuroSense announced the signing of a binding term sheet with a strategic partner to advance the development and commercialization of PrimeC, its lead drug candidate for ALS. This marks a crucial step in bringing a much-needed treatment to ALS patients worldwide.
Legal Expertise That Drives Innovation
As a law firm specializing in data protection, compliance, and regulatory matters, we understand the complex legal landscape surrounding biotech and pharmaceutical advancements. Our team at Or-Hof Law is proud to support NeuroSense with tailored legal strategies, ensuring compliance with evolving regulations while facilitating their growth and success.
This latest achievement by NeuroSense exemplifies the power of innovation, dedication, and strategic collaboration in the healthcare sector. We look forward to witnessing their continued success and are honored to be part of their journey.
🔗 Read more about NeuroSense’s latest milestone: Full Article
